CLOVER HEALTH INVESTMENTS CO's ticker is CLOV and the CUSIP is 18914F103. A total of 176 filers reported holding CLOVER HEALTH INVESTMENTS CO in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $300 | -77.5% | 277,689 | -81.3% | 0.03% | -80.5% |
Q2 2023 | $1,335 | +308.3% | 1,487,808 | +285.1% | 0.13% | +315.6% |
Q1 2023 | $327 | +373.9% | 386,365 | +417.6% | 0.03% | +255.6% |
Q4 2022 | $69 | -100.0% | 74,651 | +3.6% | 0.01% | -60.9% |
Q2 2022 | $154,000 | +8.5% | 72,032 | +80.3% | 0.02% | +21.1% |
Q1 2022 | $142,000 | -28.6% | 39,952 | +51.5% | 0.02% | -42.4% |
Q1 2021 | $199,000 | – | 26,375 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudson Structured Capital Management Ltd. | 1,973,944 | $7,008,000 | 16.49% |
Lee Financial Group Hawaii, Inc. | 85 | $24,000,000 | 16.36% |
Summit Rock Advisors, LP | 210,639 | $748,000 | 0.46% |
CTC Capital Management, LLC | 30,800 | $109,000 | 0.29% |
SAGE RHINO CAPITAL LLC | 261,500 | $928,000 | 0.28% |
University of Massachusetts Foundation, Inc. | 70,049 | $249,000 | 0.23% |
EQUITEC PROPRIETARY MARKETS, LLC | 161,757 | $574,000 | 0.13% |
Gainplan LLC | 45,767 | $162,000 | 0.12% |
Bayesian Capital Management, LP | 211,500 | $751,000 | 0.11% |
Perceptive Advisors | 1,500,000 | $5,325,000 | 0.11% |